Chemotherapy of metastatic triple negative breast cancer: Experience of using platinum-based chemotherapy

類似資料

• Development and validation of nomograms of outcomes for first-line platinum-based chemotherapy for metastatic triple-negative breast cancer: patient-level analysis of five prospective clinical trials in China
  著者:: Chengcheng Gong, 等
  出版事項: (2025-11-01)
• Cisplatin shows greater efficacy than gemcitabine when combined with nab-paclitaxel in metastatic triple-negative breast cancer
  著者:: Li, Yi, 等
  出版事項: (2019)
• A phase II trial of biweekly vinorelbine and oxaliplatin in second- or third-line metastatic triple-negative breast cancer
  著者:: Zhang, Jian, 等
  出版事項: (2015)
• Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple-negative metastatic breast cancer
  著者:: Zhang, Jian, 等
  出版事項: (2017)
• An explorative analysis of the prognostic value of lactate dehydrogenase for survival and the chemotherapeutic response in patients with advanced triple-negative breast cancer
  著者:: Jia, Zhenya, 等
  出版事項: (2018)